Rina Falb-Zilkha
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Neurofilament Light Chain Measurements by Centaur and Simoa Systems in Human and Murine Samples.
Journal: The Israel Medical Association journal : IMAJ
Published: February 25, 2026
Myelin-specific IL2 + T-cells are associated with last occurring relapse severity in relapsing-remitting multiple sclerosis.
Journal: Scientific reports
Published: October 16, 2025
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects.
Journal: International journal of molecular sciences
Published: August 31, 2025
Machine learning-based prediction of disease progression in primary progressive multiple sclerosis.
Journal: Brain communications
Published: May 30, 2024
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: May 30, 2022
Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study.
Journal: PloS one
Published: March 14, 2022
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
Journal: Journal of neuroimmunology
Published: August 31, 2021
Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients.
Journal: Annals of clinical and translational neurology
Published: March 05, 2020
Polymerase-1 pathway activation in acute multiple sclerosis relapse.
Journal: Autoimmunity reviews
Published: July 01, 2018
Experimental Autoimmune Encephalomyelitis Ameliorated by Passive Transfer of Polymerase 1-Silenced MOG35-55 Lymphatic Node Cells: Verification of a Novel Therapeutic Approach in Multiple Sclerosis.
Journal: Neuromolecular medicine
Published: February 23, 2017
RAM-589.555 a new Polymerase-1 inhibitor as innovative targeted-treatment for multiple sclerosis.
Journal: Journal of neuroimmunology
Published: August 23, 2016
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients.
Journal: Journal of neurovirology
Published: December 12, 2015
Last Updated: 09/26/2026